Dr. Samuel Louie
Pulmonary Disease · Sacramento, CA
CMS Profile ID: 173426 · NPI: 1811972920
F
Payment Grade
High payments ($100,000+). This grade reflects disclosed general payments in CMS Open Payments program year 2024 only.
Total Disclosed Payments
$525,653
Number of Payments
428
Transparency Score
1/5
Payments by Type
| Payment Type | Amount |
|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $450,065 |
| Travel and Lodging | $64,044 |
| Food and Beverage | $9,544 |
| Consulting Fee | $2,000 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| GENZYME CORPORATION | $170,172 |
| AstraZeneca Pharmaceuticals LP | $154,208 |
| Regeneron Healthcare Solutions, Inc. | $113,592 |
| GlaxoSmithKline, LLC. | $85,436 |
| Electromed, Inc. | $2,246 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2024 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by name or NPI on the
official CMS Open Payments portal.
What should I ask my doctor?
- Are you a paid speaker or consultant for any pharmaceutical or device company?
- Do any of your prescribing choices reflect relationships with industry?
- Is there an equivalent generic or alternative treatment?